NFJ Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.7M Buy
71,473
+17,960
+34% +$18.4M 2.9% 4
2026
Q1
$49.2M Buy
53,513
+28,632
+115% +$29M 1.86% 9
2025
Q4
$26.7M Sell
24,881
-3,691
-13% -$3.53M 0.96% 32
2025
Q3
$21.8M Buy
28,572
+4,209
+17% +$3.13M 0.75% 49
2025
Q2
$19M Hold
24,363
0.66% 48
2025
Q1
$20.1M Buy
24,363
+10,337
+74% +$8.6M 0.68% 51
2024
Q4
$10.8M Buy
+14,026
New +$11.6M 0.35% 87

Other funds holding LLY

NFJ Investment Group's LLY Position: Q2 2026 in Review

NFJ Investment Group increased its Eli Lilly (LLY) stake by 34% in Q2 2026, buying an estimated $18.4M and bringing the position to 71,473 shares worth $85.7M. The position accounts for 2.9% of the portfolio, ranked #4.

NFJ Investment Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NFJ Investment Group held 71,473 shares of Eli Lilly worth $85.7M as of Q2 2026.
  • NFJ Investment Group bought 17,960 Eli Lilly shares in Q2 2026, an estimated $18.4M.
  • Eli Lilly made up 2.9% of NFJ Investment Group's portfolio in Q2 2026, its #4 holding.
  • NFJ Investment Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.